主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Frisco Holding II | 是 | 3889.67万 | 17.40% | 新增 | 新增 | -- |
| 2 | Hercules Holding II, LLC | 是 | 3462.25万 | 15.50% |
|
|
-- |
| 3 | 领航集团有限公司 | 是 | 1692.92万 | 7.60% | 不变 | 不变 | -- |
| 4 | Samuel N. Hazen | 否 | 216.41万 | 0.97% |
|
|
0.9680% |
| 5 | William R. Frist | 否 | 41.59万 | 0.19% |
|
|
0.1860% |
| 6 | Jon M. Foster | 否 | 30.79万 | 0.14% |
|
|
0.1377% |
| 7 | Michael A. Marks | 否 | 13.36万 | 0.06% |
|
|
0.0597% |
| 8 | Michael S. Cuffe | 否 | 8.47万 | 0.04% |
|
|
0.0379% |
| 9 | Michael R. McAlevey | 否 | 3.82万 | 0.02% |
|
|
0.0171% |
| 10 | Robert J. Dennis | 否 | 2.66万 | 0.01% |
|
|
0.0119% |
| 11 | Nancy Ann DeParle | 否 | 2.14万 | 0.0096% |
|
|
0.0096% |
| 12 | Thomas F. Frist III | 否 | 1.48万 | 0.0066% |
|
|
0.0066% |
| 13 | Wayne J. Riley | 否 | 1.45万 | 0.0065% |
|
|
0.0065% |
| 14 | Michael W. Michelson | 否 | 1.17万 | 0.0052% |
|
|
0.0052% |
| 15 | Andrea B. Smith | 否 | 0.42万 | 0.0019% |
|
|
0.0019% |
| 16 | Hugh F. Johnston | 否 | 0.37万 | 0.0016% |
|
|
0.0016% |
| 17 | John W. Chidsey | 否 | 0.05万 | 0.0002% | 新增 | 新增 | 0.0002% |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2026-02-13 | McAlevey Michael R |
|
1.39 | 236.61 | 是 | EVP & Chief Legal & Admin Off. |
| 2026-02-13 | McAlevey Michael R |
|
1.05 | 540.29 | 是 | EVP & Chief Legal & Admin Off. |
| 2026-02-13 | McAlevey Michael R |
|
0.89 | 533.37 | 是 | EVP & Chief Legal & Admin Off. |
| 2026-02-10 | Berres Jennifer |
|
2.25 | 0.00 | 是 | SVP & Chief Human Res. Officer |
| 2026-02-10 | Berres Jennifer |
|
2.00 | 502.05 | 是 | SVP & Chief Human Res. Officer |
| 2026-02-10 | Berres Jennifer |
|
1.60 | 503.00 | 是 | SVP & Chief Human Res. Officer |
| 2026-02-10 | Berres Jennifer |
|
1.20 | 526.16 | 是 | SVP & Chief Human Res. Officer |
| 2026-02-10 | Cuffe Michael S. |
|
3.56 | 0.00 | 是 | EVP and Chief Clinical Officer |
| 2026-02-10 | Cuffe Michael S. |
|
3.21 | 502.05 | 是 | EVP and Chief Clinical Officer |
| 2026-02-10 | Foster Jon M |
|
2.90 | 0.00 | 是 | EVP and COO |
| 2026-02-10 | Foster Jon M |
|
2.31 | 502.05 | 是 | EVP and COO |
| 2026-02-10 | HAZEN SAMUEL N |
|
8.62 | 0.00 | 是 | CEO |
| 2026-02-10 | HAZEN SAMUEL N |
|
6.48 | 502.05 | 是 | CEO |
| 2026-02-10 | Marks Mike A |
|
0.50 | 0.00 | 是 | EVP and CFO |
| 2026-02-10 | Marks Mike A |
|
0.33 | 502.05 | 是 | EVP and CFO |
| 2026-02-10 | McAlevey Michael R |
|
1.19 | 0.00 | 是 | EVP & Chief Legal & Admin Off. |
| 2026-02-10 | McAlevey Michael R |
|
0.89 | 502.05 | 是 | EVP & Chief Legal & Admin Off. |
| 2026-02-10 | Rossitto Erica |
|
1.08 | 0.00 | 是 | SVP & Chief Nurse Executive |
| 2026-02-10 | Rossitto Erica |
|
1.04 | 502.05 | 是 | SVP & Chief Nurse Executive |
| 2026-02-10 | Wyatt Christopher F. |
|
4.94 | 0.00 | 是 | SVP & Controller |
| 2026-02-10 | Wyatt Christopher F. |
|
4.84 | 502.05 | 是 | SVP & Controller |
| 2026-02-10 | Wyatt Christopher F. |
|
4.44 | 505.00 | 是 | SVP & Controller |
| 2026-02-06 | Frisco Holding II |
|
-- | -- | 是 | -- |
| 2026-02-06 | Frisco Holding II |
|
3655.71 | -- | 是 | -- |
| 2026-02-06 | HERCULES HOLDING II |
|
3228.29 | 0.00 | 是 | -- |
| 2026-02-05 | Foster Jon M |
|
2.93 | 139.06 | 是 | EVP and COO |
| 2026-02-05 | Foster Jon M |
|
1.33 | 513.76 | 是 | EVP and COO |
| 2026-02-05 | Wyatt Christopher F. |
|
5.17 | 139.06 | 是 | SVP & Controller |
| 2026-02-05 | Wyatt Christopher F. |
|
4.61 | 513.76 | 是 | SVP & Controller |
| 2026-02-03 | Cuffe Michael S. |
|
3.00 | 498.09 | 是 | EVP and Chief Clinical Officer |
| 2026-02-03 | Cuffe Michael S. |
|
2.60 | 0.00 | 是 | EVP and Chief Clinical Officer |
| 2026-02-03 | HAZEN SAMUEL N |
|
6.04 | 502.95 | 是 | CEO |
| 2026-02-03 | HAZEN SAMUEL N |
|
5.54 | 502.15 | 是 | CEO |
| 2026-02-03 | HAZEN SAMUEL N |
|
4.80 | 500.69 | 是 | CEO |
| 2026-02-03 | HAZEN SAMUEL N |
|
4.19 | 500.02 | 是 | CEO |
| 2026-02-03 | HAZEN SAMUEL N |
|
3.67 | 498.80 | 是 | CEO |
| 2026-02-03 | HAZEN SAMUEL N |
|
3.24 | 498.12 | 是 | CEO |
| 2026-02-03 | HAZEN SAMUEL N |
|
3.23 | 497.18 | 是 | CEO |
| 2026-02-03 | HAZEN SAMUEL N |
|
3.12 | 498.35 | 是 | CEO |
| 2026-01-29 | HAZEN SAMUEL N |
|
11.66 | 81.96 | 是 | CEO |
| 2026-01-29 | HAZEN SAMUEL N |
|
7.52 | 488.27 | 是 | CEO |
| 2025-11-14 | HAZEN SAMUEL N |
|
3.23 | 0.00 | 是 | CEO |
| 2025-11-03 | Marks Mike A |
|
0.02 | 0.00 | 是 | EVP and CFO |
| 2025-11-03 | Marks Mike A |
|
-- | 0.00 | 是 | EVP and CFO |
| 2025-11-03 | McAlevey Michael R |
|
0.35 | 473.79 | 是 | EVP & Chief Legal & Admin Off. |
| 2025-11-03 | McAlevey Michael R |
|
1.67 | 236.61 | 是 | EVP & Chief Legal & Admin Off. |
| 2025-11-03 | McAlevey Michael R |
|
0.74 | 461.56 | 是 | EVP & Chief Legal & Admin Off. |
| 2025-10-31 | HAZEN SAMUEL N |
|
7.53 | 69.58 | 是 | CEO |
| 2025-10-31 | HAZEN SAMUEL N |
|
4.71 | 459.68 | 是 | CEO |
| 2025-09-04 | Cuffe Michael S. |
|
4.24 | 173.12 | 是 | EVP and Chief Clinical Officer |
| 2025-09-04 | Cuffe Michael S. |
|
3.53 | 411.59 | 是 | EVP and Chief Clinical Officer |
| 2025-09-04 | Cuffe Michael S. |
|
3.15 | 418.84 | 是 | EVP and Chief Clinical Officer |
| 2025-07-29 | CHIDSEY JOHN |
|
0.05 | 0.00 | 是 | -- |
| 2025-05-13 | Foster Jon M |
|
1.26 | 369.32 | 是 | EVP and COO |
| 2025-05-13 | Foster Jon M |
|
1.16 | 0.00 | 是 | EVP and COO |
| 2025-05-06 | Marks Mike A |
|
-- | 0.00 | 是 | EVP and CFO |
| 2025-05-06 | Marks Mike A |
|
0.03 | 353.58 | 是 | EVP and CFO |
| 2025-05-06 | Marks Mike A |
|
0.01 | 0.00 | 是 | EVP and CFO |
| 2025-05-06 | Marks Mike A |
|
-- | 0.00 | 是 | EVP and CFO |
| 2025-04-29 | Dennis Robert J |
|
2.66 | 0.00 | 是 | -- |
| 2025-04-29 | Johnston Hugh F |
|
0.37 | 0.00 | 是 | -- |
| 2025-04-29 | MICHELSON MICHAEL W |
|
1.17 | 0.00 | 是 | -- |
| 2025-04-29 | Riley Wayne Joseph |
|
1.45 | 0.00 | 是 | -- |
| 2025-04-29 | DEPARLE NANCY ANN |
|
2.14 | 0.00 | 是 | -- |
| 2025-04-29 | Smith Andrea B |
|
0.42 | 0.00 | 是 | -- |
| 2025-04-29 | FRIST THOMAS F III |
|
1.48 | 0.00 | 是 | -- |
| 2025-04-29 | Frist William R |
|
1.29 | 0.00 | 是 | -- |
| 2025-02-13 | Wyatt Christopher F. |
|
4.13 | 0.00 | 是 | SVP & Controller |
| 2025-02-13 | Wyatt Christopher F. |
|
4.11 | 321.92 | 是 | SVP & Controller |
| 2025-02-13 | McAlevey Michael R |
|
0.27 | 321.92 | 是 | EVP & Chief Legal & Admin Off. |
| 2025-02-13 | Mosier Sammie S |
|
1.13 | 0.00 | 是 | SVP & Chief Nurse Executive |
| 2025-02-13 | Mosier Sammie S |
|
1.11 | 321.92 | 是 | SVP & Chief Nurse Executive |
| 2025-02-13 | McAlevey Michael R |
|
0.32 | 0.00 | 是 | EVP & Chief Legal & Admin Off. |
| 2025-02-13 | Marks Mike A |
|
0.06 | 0.00 | 是 | EVP and CFO |
| 2025-02-13 | Marks Mike A |
|
0.05 | 321.92 | 是 | EVP and CFO |
| 2025-02-13 | HAZEN SAMUEL N |
|
7.64 | 0.00 | 是 | CEO |
| 2025-02-13 | HAZEN SAMUEL N |
|
7.17 | 321.92 | 是 | CEO |
| 2025-02-13 | Foster Jon M |
|
2.83 | 321.92 | 是 | EVP and COO |
| 2025-02-13 | Foster Jon M |
|
2.90 | 0.00 | 是 | EVP and COO |
| 2025-02-13 | Cuffe Michael S. |
|
3.20 | 0.00 | 是 | EVP and Chief Clinical Officer |
| 2025-02-13 | Cuffe Michael S. |
|
3.14 | 321.92 | 是 | EVP and Chief Clinical Officer |
| 2025-02-13 | Berres Jennifer |
|
2.49 | 321.92 | 是 | SVP & Chief Human Res. Officer |
| 2025-02-13 | Berres Jennifer |
|
2.54 | 0.00 | 是 | SVP & Chief Human Res. Officer |
| 2025-02-13 | Berres Jennifer |
|
2.08 | 322.96 | 是 | SVP & Chief Human Res. Officer |
| 2025-02-13 | Berres Jennifer |
|
1.54 | 322.31 | 是 | SVP & Chief Human Res. Officer |
| 2025-02-07 | Berres Jennifer |
|
2.38 | 322.05 | 是 | SVP & Chief Human Res. Officer |
| 2025-02-07 | Berres Jennifer |
|
2.62 | 101.16 | 是 | SVP & Chief Human Res. Officer |
| 2025-02-07 | Berres Jennifer |
|
3.05 | 139.06 | 是 | SVP & Chief Human Res. Officer |
| 2025-02-03 | Mosier Sammie S |
|
1.05 | -- | 是 | SVP & Chief Nurse Executive |
| 2024-11-14 | Whalen Kathleen M |
|
0.95 | 357.99 | 是 | SVP & Chief Ethics Officer |
| 2024-11-12 | Akdamar Erol R |
|
2.00 | 68.96 | 是 | Group President |
| 2024-11-12 | Akdamar Erol R |
|
0.97 | 350.53 | 是 | Group President |
| 2024-11-12 | Akdamar Erol R |
|
0.68 | 353.00 | 是 | Group President |
| 2024-11-12 | Billington Phillip G |
|
6.07 | 68.96 | 是 | SVP-Internal Audit Services |
| 2024-11-12 | Billington Phillip G |
|
5.66 | 350.53 | 是 | SVP-Internal Audit Services |
| 2024-11-12 | Billington Phillip G |
|
5.27 | 350.00 | 是 | SVP-Internal Audit Services |
| 2024-11-11 | Whalen Kathleen M |
|
1.42 | 173.12 | 是 | SVP & Chief Ethics Officer |
| 2024-11-11 | Whalen Kathleen M |
|
1.09 | 357.99 | 是 | SVP & Chief Ethics Officer |
| 2024-09-10 | Cuffe Michael S. |
|
5.18 | 145.24 | 是 | EVP and Chief Clinical Officer |
| 2024-09-10 | Cuffe Michael S. |
|
3.80 | 386.43 | 是 | EVP and Chief Clinical Officer |
| 2024-09-10 | Cuffe Michael S. |
|
2.97 | 385.42 | 是 | EVP and Chief Clinical Officer |
| 2024-08-08 | Marks Mike A |
|
-- | 0.00 | 是 | EVP and CFO |
| 2024-08-06 | HAZEN SAMUEL N |
|
7.83 | 0.00 | 是 | CEO |
| 2024-08-06 | HAZEN SAMUEL N |
|
6.62 | 0.00 | 是 | CEO |
| 2024-08-06 | HAZEN SAMUEL N |
|
6.32 | 0.00 | 是 | CEO |
| 2024-08-05 | Sowell Joseph A III |
|
-- | 0.00 | 是 | SVP; Chief Development Officer |
| 2024-07-31 | McManus Timothy M |
|
3.09 | 77.13 | 是 | Group President |
| 2024-07-31 | McManus Timothy M |
|
2.70 | 363.05 | 是 | Group President |
| 2024-07-29 | Reiner Deborah M |
|
0.35 | 359.96 | 是 | SVP - Mktg. & Communications |
| 2024-07-29 | Whalen Kathleen M |
|
1.96 | 145.24 | 是 | SVP & Chief Ethics Officer |
| 2024-07-29 | Whalen Kathleen M |
|
1.43 | 358.73 | 是 | SVP & Chief Ethics Officer |
| 2024-07-29 | Whalen Kathleen M |
|
1.24 | 359.92 | 是 | SVP & Chief Ethics Officer |
| 2024-07-29 | Whalen Kathleen M |
|
0.95 | 363.51 | 是 | SVP & Chief Ethics Officer |
| 2024-07-25 | Wyatt Christopher F. |
|
4.97 | 101.16 | 是 | SVP & Controller |
| 2024-07-25 | Wyatt Christopher F. |
|
4.44 | 352.79 | 是 | SVP & Controller |
| 2024-07-25 | Wyatt Christopher F. |
|
4.04 | 360.20 | 是 | SVP & Controller |
| 2024-07-25 | Torres Kathryn A. |
|
1.78 | 355.05 | 是 | SVP-Payer Contracting & Align. |
| 2024-05-16 | Whalen Kathleen M |
|
1.13 | 322.86 | 是 | SVP & Chief Ethics Officer |
| 2024-05-16 | Whalen Kathleen M |
|
0.95 | 326.30 | 是 | SVP & Chief Ethics Officer |
| 2024-05-16 | Whalen Kathleen M |
|
1.25 | 101.16 | 是 | SVP & Chief Ethics Officer |
| 2024-05-16 | Whalen Kathleen M |
|
1.42 | 133.53 | 是 | SVP & Chief Ethics Officer |
| 2024-05-15 | Torres Kathryn A. |
|
1.96 | 326.18 | 是 | SVP-Payer Contracting & Align. |
| 2024-05-15 | Sowell Joseph A III |
|
2.33 | 68.96 | 是 | SVP; Chief Development Officer |
| 2024-05-15 | Sowell Joseph A III |
|
1.34 | 326.96 | 是 | SVP; Chief Development Officer |
| 2024-05-15 | Foster Jon M |
|
4.72 | 101.16 | 是 | EVP and COO |
| 2024-05-15 | Foster Jon M |
|
2.63 | 345.51 | 是 | EVP and COO |
| 2024-05-15 | Foster Jon M |
|
3.05 | 352.74 | 是 | EVP and COO |
| 2024-05-15 | Foster Jon M |
|
2.86 | 0.00 | 是 | EVP and COO |
| 2024-05-15 | Foster Jon M |
|
1.06 | 0.00 | 是 | EVP and COO |
| 2024-05-09 | Cohen Jeffrey E. |
|
0.52 | 313.00 | 是 | SVP-Government Relations |
| 2024-05-09 | Akdamar Erol R |
|
-- | 0.00 | 是 | Group President |
| 2024-05-09 | Cuffe Michael S. |
|
2.96 | 316.88 | 是 | EVP and Chief Clinical Officer |
| 2024-05-06 | Cuffe Michael S. |
|
3.41 | 309.00 | 是 | EVP and Chief Clinical Officer |
| 2024-05-06 | Cuffe Michael S. |
|
5.28 | 139.06 | 是 | EVP and Chief Clinical Officer |
| 2024-05-06 | Cuffe Michael S. |
|
4.04 | 314.45 | 是 | EVP and Chief Clinical Officer |
| 2024-05-06 | Cuffe Michael S. |
|
3.59 | 0.00 | 是 | EVP and Chief Clinical Officer |
| 2024-05-02 | Torres Kathryn A. |
|
2.24 | 312.00 | 是 | SVP-Payer Contracting & Align. |
| 2024-05-02 | Torres Kathryn A. |
|
2.15 | 312.00 | 是 | SVP-Payer Contracting & Align. |
| 2024-04-29 | Marks Mike A |
|
0.22 | 0.00 | 是 | EVP and CFO |
| 2024-04-29 | Dennis Robert J |
|
2.56 | 0.00 | 是 | -- |
| 2024-04-29 | MICHELSON MICHAEL W |
|
1.05 | 0.00 | 是 | -- |
| 2024-04-29 | Johnston Hugh F |
|
0.26 | 0.00 | 是 | -- |
| 2024-04-29 | Riley Wayne Joseph |
|
1.39 | 0.00 | 是 | -- |
| 2024-04-29 | Smith Andrea B |
|
0.35 | 0.00 | 是 | -- |
| 2024-04-29 | Frist William R |
|
1.19 | 0.00 | 是 | -- |
| 2024-04-29 | FRIST THOMAS F III |
|
1.35 | 0.00 | 是 | -- |
| 2024-04-29 | CROFTON MEG |
|
0.63 | 0.00 | 是 | -- |
| 2024-04-29 | DEPARLE NANCY ANN |
|
2.08 | 0.00 | 是 | -- |